To determine the clinical relationship between ITGA2 and p-AKT in human ovarian cancer specimens, we analyzed the protein expression level of ITGA2 and phosphorylation level of AKT in a cohort of ovarian cancer patients immunohistochemically (n = 65). This evidence concerns the gene ITGA2 and ovarian carcinoma.